ENV-294

· Enveda Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ENV-294, covering 2026-04-01 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 2]